Načítá se...
Targeted therapies of the LKB1/AMPK pathway for the treatment of insulin resistance
Type 2 diabetes is characterized by elevated serum glucose levels and altered lipid metabolism, due to peripheral insulin resistance and defects of insulin secretion by the pancreatic β-cells. While some cases of obesity and Type 2 diabetes result from genetic dysfunction, the increased worldwide in...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2010
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4122297/ https://ncbi.nlm.nih.gov/pubmed/21428801 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4155/fmc.10.264 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|